Court preliminarily approves CareDx shareholder derivative settlement with governance reforms

CareDx, Inc.

Preliminary approval granted Dec 9 for settlement of Edelman v. Bickerstaff derivative action alleging false testing revenue statements.
Settlement requires CareDx to implement governance reforms (audit committee, disclosure committee, compliance review) for 4 years.
Compliance assessment budget of $250k in FY2026; $250k/year for FY2027-28 for implementation and monitoring.
Plaintiffs' counsel may seek up to $1.2M in fees/expenses (opposed by defendants); no monetary recovery for shareholders.
Final approval hearing set for June 30, 2026; settlement also resolves related Delaware derivative action (Burns IRA).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.